A hnRNPA2B1 agonist effectively inhibits HBV and SARS-CoV-2 omicron in vivo

{{article.zuoZheEn}}

PDF(17524 KB)
PDF(17524 KB)
Protein Cell ›› 2023, Vol. 14 ›› Issue (1) : 37-50. DOI: 10.1093/procel/pwac027
RESEARCH ARTICLE

A hnRNPA2B1 agonist effectively inhibits HBV and SARS-CoV-2 omicron in vivo

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Protein Cell, 2023, 14(1): 37‒50 https://doi.org/10.1093/procel/pwac027

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
PDF(17524 KB)

Accesses

Citations

Detail
Sections
Recommended

/

〈 〉